May 9, 2020Open Access

Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Skin complications related to CSII or CGM devices are commonly reported in pediatric patients with type 1 diabetes and may lead to interruption or discontinuation of device use. Future studies are needed to elucidate the causes of these reactions and determine the best methods for prevention.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Rigo et al. (Sat,) studied this question.

synapsesocial.com/papers/69d72aab3f906f6a06bef857 https://doi.org/https://doi.org/10.1177/1932296820918894

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Allergic contact dermatitis caused by isobornyl acrylate in the Enlite glucose sensor and the Paradigm MiniMed Quick‐set insulin infusion set2019 · 57 citations
2Skin and Adhesive Issues With Continuous Glucose Monitors2014 · 70 citations
3The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial2017 · 326 citations
4Allergic contact dermatitis caused by Dermabond<sup>®</sup>2016 · 41 citations
5Dermatological Complications of Continuous Subcutaneous Insulin Infusion in Children and Adolescents2008 · 110 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo